QUINTESSENTIAL
Phase 2 Study of BMS-986393, a GPRC5D-directed CART-Cell Therapy, in Participants with Relapsed or Refractory Multiple Myeloma
Filters
Save & Share
Clear Filters
Location
Explore options near your patient - or anywhere in the US.
Diagnosis
Treatment History
BCMA Therapy
This stands for B Cell Maturation Antigen (BCMA) and includes treatments such as ide-cel, cilta-cel or belantamab mafodotin.
Near Add Your Location
Sort by
Memorial Sloan Kettering Cancer Center
New York, NY
- Not yet accepting
UCSF Helen Diller Comprehensive Cancer Center
University of California San Francisco
San Francisco, CA
- Accepting patients
- Accepting patients
- Accepting patients
University of Kansas Cancer Center
Kansas City, KS
- Accepting patients
- Accepting patients
Massachusetts General Hospital
Boston, MA
- Accepting patients
- Accepting patients
- Accepting patients
Roswell Park Cancer Institute
Buffalo, NY
- Accepting patients
1,325 hidden based on your filters. Show All
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.